ES555123A0 - Procedimiento para la formacion de hibridos celulares - Google Patents

Procedimiento para la formacion de hibridos celulares

Info

Publication number
ES555123A0
ES555123A0 ES555123A ES555123A ES555123A0 ES 555123 A0 ES555123 A0 ES 555123A0 ES 555123 A ES555123 A ES 555123A ES 555123 A ES555123 A ES 555123A ES 555123 A0 ES555123 A0 ES 555123A0
Authority
ES
Spain
Prior art keywords
sequence
culture
procedure
formation
expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555123A
Other languages
English (en)
Other versions
ES8703519A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Publication of ES8703519A1 publication Critical patent/ES8703519A1/es
Publication of ES555123A0 publication Critical patent/ES555123A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ES555123A 1985-05-02 1986-05-02 Procedimiento para la formacion de hibridos celulares Expired ES8703519A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858506706A FR2581393B2 (fr) 1985-05-02 1985-05-02 Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit

Publications (2)

Publication Number Publication Date
ES8703519A1 ES8703519A1 (es) 1987-03-01
ES555123A0 true ES555123A0 (es) 1987-03-01

Family

ID=9318906

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555123A Expired ES8703519A1 (es) 1985-05-02 1986-05-02 Procedimiento para la formacion de hibridos celulares

Country Status (12)

Country Link
US (1) US5112748A (es)
EP (1) EP0200653B1 (es)
JP (1) JPS6229971A (es)
AT (1) ATE51026T1 (es)
CA (1) CA1277934C (es)
DE (1) DE3669529D1 (es)
DK (1) DK204586A (es)
ES (1) ES8703519A1 (es)
FR (1) FR2581393B2 (es)
GR (1) GR861142B (es)
PT (1) PT82505B (es)
WO (1) WO1993013203A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7766329B1 (en) 1992-10-02 2010-08-03 Sierra Design Group Wheel indicator and ticket dispenser apparatus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757169A1 (de) * 1977-12-22 1979-07-05 Hoechst Ag Verfahren zur gewinnung insulin produzierender tierischer zellen
FR2458584A1 (fr) * 1979-06-08 1981-01-02 Pasteur Institut Vecteurs pour le transfert et l'expression de materiel genetique dans une cellule eucaryote et procede pour la production d'une proteine determinee dans des cellules eucaryotes
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
JPS6045848B2 (ja) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 ヒト成長ホルモンの製造方法
FR2500847B1 (fr) * 1981-03-02 1985-09-13 Pasteur Institut Marqueurs genetiques selectifs pour cellules eucaryotes, procede de mise en oeuvre de tels marqueurs et application des cellules contenant un tel marqueur a la fabrication de proteines determinees apres leur transformation par un adn correspondant
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
JPS58201988A (ja) * 1982-05-04 1983-11-25 ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 永久培養可能な動物及びヒトの細胞系を得る方法
US4608339A (en) * 1983-10-25 1986-08-26 Yoakum George H Protoplast fusion method for high-frequency DNA transfection in human cells
FR2555607B2 (fr) * 1983-11-30 1986-10-03 Pasteur Institut Culture de cellules eucaryotes productrices d'une proteine vaccinante, notamment d'antigene hbs
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide

Also Published As

Publication number Publication date
ES8703519A1 (es) 1987-03-01
DE3669529D1 (de) 1990-04-19
EP0200653B1 (fr) 1990-03-14
EP0200653A1 (fr) 1986-11-05
JPS6229971A (ja) 1987-02-07
ATE51026T1 (de) 1990-03-15
GR861142B (en) 1986-08-11
CA1277934C (fr) 1990-12-18
DK204586D0 (da) 1986-05-02
US5112748A (en) 1992-05-12
FR2581393A2 (fr) 1986-11-07
FR2581393B2 (fr) 1989-07-21
PT82505B (pt) 1989-12-29
DK204586A (da) 1986-11-03
WO1993013203A1 (fr) 1993-07-08
PT82505A (fr) 1986-06-01

Similar Documents

Publication Publication Date Title
DK577783D0 (da) Vektor for udtrykkelse af et dna-segment i gaer
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
BE880670A (fr) Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
CA2064705A1 (en) Methods for Culturing HCV in Eukaryotic Cells
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
DK0863202T3 (da) Rekombinant Sendai-virus
KR880014097A (ko) 바이러스-특이성 유전적 조절하에서 표시인자 유전자 산물을 발현하는 안정한 사람 세포주
ES555123A0 (es) Procedimiento para la formacion de hibridos celulares
DK498387A (da) Virus-dna-sekvens
EP0469348A3 (en) Cdna sequence and detection of hepatits c virus
DK631387D0 (da) Virusvektor
ATE259421T1 (de) Dna-virus-vektoren und verfahren zu ihrer herstellung
Bosslet et al. Biological properties and physical map of the genome of a new papovavirus, HD virus
DK0915165T3 (da) Fremgangsmåde til hjælper-virusfri pakning af et genvektor-DNA
Varmuza Recombinational and packaging signals in herpes simplex virus deoxyribonucleic acid
KR860008281A (ko) 간염 b형 표면 항원을 암호하는 재조합 dna벡터
AU8277582A (en) Method for the preparation of a dna-hybride, containing the complementary genome of the hepatitis a virus, the dna- hybride itself, the plasmic vector contain it, the specific proteins of the virus coded by the dna-hybride and vaccines containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303